Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Just checked out Tenet Healthcare's Q4 numbers and they actually came in pretty solid. EPS hit $4.70, beating estimates by over 15%, and revenue jumped to $5.53 billion with year-over-year growth of 8.9%. The thing that caught my attention was how much the payer mix improved - that really helped drive the top line beat.
Looking at the breakdown, their Hospital Operations segment saw revenues of $4.09 billion, up 7.3% YoY. What's interesting is they're attributing a good chunk of this to a favorable payer mix along with higher acuity levels. The Ambulatory Care side was even stronger, posting 13.8% revenue growth to $1.43 billion, though margins there compressed a bit.
Adjusted EBITDA came in at $1.18 billion, up 12.9%, and the margin expanded to 21.4%. They're managing costs reasonably well despite wage pressures - salaries rose 6.1% but they're still getting efficiency gains from the improved payer mix and acuity. Cash generation was solid too, with free cash flow hitting $2.5 billion in 2025.
Here's where it gets interesting though - their 2026 guidance shows some caution. They're expecting revenue between $21.5-$22.3 billion, but adjusted EBITDA margin is projected to decline slightly to the 20.9-21.5% range. So while the top line keeps growing and the payer mix story continues, margin expansion might be tougher. They're guiding EPS between $16.19-$18.47 next year, which is actually down from the $16.78 they just posted. Worth keeping an eye on how the payer mix evolves as we move through 2026.